IainRossMcDougallMD

Nuclear Medicine • Stanford, CA

Professor Emeritus, Nuclear Medicine, Stanford University Medical Center

Join to view full profile

Are you Dr. McDougall?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 14 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
300 Pasteur Dr
Stanford, CA 94305
Phone+1 650-498-5710
Is this information wrong?

Summary

Dr. Iain McDougall, MD is a board certified nuclear medicine physician in Stanford, California. He is currently licensed to practice medicine in California. He is affiliated with Stanford Health Care and Lucile Packard Children's Hospital Stanford.

Education & Training

University of Glasgow Faculty of MedicineClass of 1967

Certifications & Licensure

CA State Medical License 1977 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Nuclear Medicine Nuclear Medicine

Clinical Trials

Comparison of I-124 PET/CT, F-18 FDG PET/CT & I-123 Whole Body Scintigraphy for Recurrent Thyroid CA Start of enrollment: 2007 May 01
Withdrawn

Publications & Presentations

PubMed

119 citations
Radiation Safety in the Treatment of Patients with Thyroid Diseases by Radioiodine 131I: Practice Recommendations of the American Thyroid Association
James C. Sisson, John Freitas, McDougall Ir, Lawrence T. Dauer, James R. Hurley, James D. Brierley, Charlotte H. Edinboro, David Rosenthal, Michael J. Thomas, Jason A....> ;Thyroid. 2011 Apr 5
32 citations
18F-FDG PET/CT evaluation of patients with ovarian carcinoma.
Andrei Iagaru, Erik Mittra, McDougall Ir, Andrew Quon, Sanjiv S. Gambhir> ;Nuclear Medicine Communications. 2008 Dec 1
5 citations
ATA Guidelines: do patients with stage I thyroid cancer benefit from (131)I?
McDougall Ir, Hay Id> ;Thyroid. 2007 Jun 1
40 citations
2-Deoxy-2-[F-18]fluoro- d -glucose Positron Emission Tomography/Computed Tomography in the Management of Melanoma
Andrei Iagaru, Andrew Quon, Denise L. Johnson, SS Gambhir, McDougall Ir> ;Molecular Imaging and Biology. 2007 Jan 1
7 citations
F-18 FDG PET/CT demonstration of an adrenal metastasis in a patient with anaplastic thyroid cancer.
Andrei Iagaru, McDougall Ir> ;Clinical Nuclear Medicine. 2007 Jan 1
29 citations
Merkel Cell Carcinoma: Is there a Role for 2-Deoxy-2-[F-18]fluoro-d-glucose-Positron Emission Tomography/Computed Tomography?
Andrei Iagaru, Andrew Quon, McDougall Ir, Sanjiv S. Gambhir> ;Molecular Imaging and Biology. 2006 May 25
41 citations
Positron emission tomography of the thyroid, with an emphasis on thyroid cancer.
McDougall Ir, J. Davidson, George M. Segall> ;Nuclear Medicine Communications. 2001 May 1
29 citations
Recombinant human thyrotropin in the management of thyroid cancer.
McDougall Ir, Ronald J. Weigel> ;Current Opinion in Oncology. 2001 Jan 1
188 citations
Ultrasound-Guided Fine-Needle Aspiration Biopsy of Thyroid Masses
Charles Carmeci, R. Brooke Jeffrey, McDougall Ir, Kent W. Nowels, Ronald J. Weigel> ;Thyroid. 1998 Apr 1
70 citations
74 MBq radioiodine 131I does not prevent uptake of therapeutic doses of 131I (i.e. it does not cause stunning) in differentiated thyroid cancer
McDougall Ir> ;Nuclear Medicine Communications. 1997 Jun 1
338 citations
Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer
Peter Singer, David S. Cooper, Gilbert H. Daniels, Paul W. Ladenson, Francis S. Greenspan, Elliot G. Levy, Lewis E. Braverman, Orlo H. Clark, McDougall Ir, K V Ain, S ...> ;Archives of Internal Medicine. 1996 Oct 28
Adherence of radiopharmaceuticals and labeled cells to intravenous tubing.
George M. Segall, Gurevich N, McDougall Ir> ;Clinical Nuclear Medicine. 1986 Dec 1
1 citations
The diagnosis of thyrotoxicosis.
W. R. Greig, Iain R. Mcdougall, Henry M. W. Gray> ;Postgraduate Medical Journal. 1973 Jul 1
A technique for intraoperative bone scintigraphy. A report of 17 cases.
Klonecke, A. S., Licho, R., McDougall, I. R.> ;Clin Nucl Med. 1991 Jul
Complications of fractures and their healing.
McDougall, I. R., Keeling, C. A.> ;Semin Nucl Med. 1988 Apr
Metastatic malignant struma ovarii presenting as paraparesis from a spinal metastasis.
McDougall, I. R., Krasne, D., Hanbery, J. W., Collins, J. A.> ;J Nucl Med. 1989 Mar
Scintigraphic techniques in musculoskeletal trauma.
McDougall, I. R., Rieser, R. P.> ;Radiol Clin North Am. 1989 Sep
Management of thyroid papillary carcinoma with radioiodine in a patient with end stage renal disease on hemodialysis.
Mello, A. M., Isaacs, R., Petersen, J., Kronenberger, S., McDougall, I. R.> ;Clin Nucl Med. 1994 Sep
Follow-up of patients with differentiated thyroid cancer using serum thyroglobulin measured by an immunoradiometric assay. Comparison with I-131 total body scans.
McDougall, I. R., Bayer, M. F.> ;J Nucl Med. 1980 Aug
Papillary carcinoma of the thyroid seven years after I-131 therapy for Graves' disease.
McDougall, I. R., Nelsen, T. S., Kempson, R. L.> ;Clin Nucl Med. 1981 Aug
Thyroid carcinoma following iodine-131 therapy. Report of a case and review of the literature.
McDougall, I. R., Kennedy, J. S., Thomson, J. A.> ;J Clin Endocrinol Metab. 1971 Aug
125I therapy in Graves'' disease. Long-term results in 355 patients.
McDougall, I. R., Greig, W. R.> ;Ann Intern Med. 1976 Dec
Scintigraphic hot nodules and thyroid carcinoma.
Nagai, G. R., Pitts, W. C., Basso, L., Cisco, J. A., McDougall, I. R.> ;Clin Nucl Med. 1987 Feb 01
How frequently is the thymus seen on whole-body iodine-131 diagnostic and post-treatment scans?
Davidson, J., McDougall, I. R.> ;Eur J Nucl Med. 2000 Apr
Uptake of I-131 in the biliary tract: a potential cause of a false-positive result of scintiscan.
Carlisle, M., Cortés, A., McDougall, I. R.> ;Clin Nucl Med. 1998 Aug
Join now to see all

Hospital Affiliations

Lucile Packard Children's Hospital StanfordPalo Alto, California
Stanford Health CarePalo Alto, California